An in vitro one pot synthetic biology approach to emulating Golgi O-glycosylation divergence in MUC1 and tumor associated MUC1

Kevin Naidoo,Abdullateef Nashed

DOI: https://doi.org/10.26434/chemrxiv-2024-bq9ct

2024-07-26

Abstract:Peptide O-glycosylation is a non-template driven process dependent on an orchestrated collaboration of glycosyltransferases (GTs) in the ER and golgi apparatus. An in vitro modelling of this requires an understanding of GT specificities, kinetics and their spatial distribution along the ER-Golgi axis. This study explores the specificity and kinetics of O-GalNAc glyco-sylation on a designed tandem repeat of MUC1 (23mer), a protein significantly implicated in cancer progression. Using an in vitro one-pot synthetic biology approach, MUC1 glycopeptides were produced, and GT specificity for cancer-associated anti-gens Tn, T, and their sialylated forms were assessed. The impact of GT re-localization from the ER to Golgi on glycosyla-tion patterns was modelled and analyzed. The model suggests that presenting MUC1 to GALNTs in isolation from other GTs, namely C1GALT1 and ST6GALNAC1 significantly increases the extent of site occupancy by Tn a tumour epitope. This mimics the ER localization of GALNTs associated with cancer. In contrast when MUC1 is presented to GALNTs in combination with C1GALT1 there is a decline in observed occupancy. Our modelling shows this to be the result of a com-petition between the secondary glycosylation of the GalNac sites by C1GALT1 and the GALNTs’ lectins that need to bind to the GalNac sites to further proceed with the primary glycosylation of adjacent free sites. In the case of normal MUC1 C1GALT1 shows greater specificity to the under-occupied (GalNAc3-23mer) form of Tn. In the cancer case ST6GALNAC1 shows greater specificity to the fully occupied form (GalNAc5-23mer). These results suggest a mechanism of regulation of tumour associated MUC1 antigens independent of GTs expression level.

Chemistry

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to simulate and study the O - linked glycosylation process of MUC1 protein in vitro, especially the glycosylation differences of tumor - associated MUC1 (TA - MUC1). Specifically, the research aims to explore the specificity and kinetics of specific glycosyltransferases (GTs) for MUC1 peptides through an in - vitro one - pot synthetic biology method, and how the relocation of these enzymes on the endoplasmic reticulum (ER) - to - Golgi axis affects the glycosylation pattern. The core problems of the paper are: 1. **Understanding the specificity and kinetics of glycosyltransferases (such as GALNTs, C1GALT1 and ST6GALNAC1) in MUC1 glycosylation**: Study the specificity of different glycosyltransferases for specific MUC1 glycosylation sites (such as Tn, T and their sialylated forms), and analyze the kinetic parameters of these enzymes. 2. **Simulating and analyzing the impact of the relocation of glycosyltransferases on the ER - to - Golgi axis on the glycosylation pattern**: Explore the changes in the glycosylation pattern when GALNTs are relocated from the ER to the Golgi, and how this change affects the formation of tumor - associated antigens. 3. **Revealing the difference mechanism between normal MUC1 and tumor - associated MUC1 glycosylation patterns**: Through in - vitro experiments, study the influence of different glycosyltransferase combinations on MUC1 glycosylation, especially the competitive effects of C1GALT1 and ST6GALNAC1 at different glycosylation sites, and how these competitions lead to different glycosylation patterns between normal MUC1 and TA - MUC1. Through these studies, the paper hopes to provide new insights into understanding the glycosylation changes of MUC1 in cancer progression and provide a theoretical basis for the development of cancer treatment strategies targeting MUC1 glycosylation.

An in vitro one pot synthetic biology approach to emulating Golgi O-glycosylation divergence in MUC1 and tumor associated MUC1

Characterization of a Bacterial Beta-1,3-galactosyltransferase with Application in the Synthesis of Tumor-Associated T-antigen Mimics.

Muc1 Glycopeptide Epitopes Predicted By Computational Glycomics

Synthesis and Thermodynamic Evaluation of Sialyl‐Tn MUC1 Glycopeptides Binding to Macrophage Galactose‐Type Lectin

An efficient approach for the characterization of mucin-type glycopeptides: the effect of O-glycosylation on the conformation of synthetic mucin peptides

The Breast Cancer-Associated Glycoforms of MUC1, MUC1-Tn and sialyl-Tn, Are Expressed in COSMC Wild-Type Cells and Bind the C-Type Lectin MGL

Glycosite Mapping and in situ Mass Spectrometry Imaging of MUC2 Glycopeptides via On-slide Digestion with Mucinase StcE

Mucin-type O-glycosylation is controlled by short- and long-range glycopeptide substrate recognition that varies among members of the polypeptide GalNAc transferase family

Dual-Probe Approach for Mass Spectrometric Quantification of MUC1-Specific Terminal Gal/GalNAc In Situ

A straightforward approach to antibodies recognising cancer specific glycopeptidic neoepitopes

O-glycosylated human MUC1 repeats are processed in vitro by immunoproteasomes

Mucins as anti-cancer targets: perspectives of the glycobiologist

Glycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killing

Short O-GalNAc glycans: regulation and role in tumor development and clinical perspectives

Synthesis and immunological evaluation of the unnatural β-linked mucin-1 Thomsen-Friedenreich conjugate

The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer

O-glycan recognition and function in mice and human cancers

Unexpected tolerance of glycosylation by UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase revealed by electron capture dissociation mass spectrometry: carbohydrate as potential protective groups

Regulatory Role of One Critical Catalytic Loop of Polypeptide N-Acetyl-Galactosaminyltransferase-2 in Substrate Binding and Catalysis During Mucin-Type O-Glycosylation

Synthesis and Immunological Evaluation of Disaccharide Bearing MUC-1 Glycopeptide Conjugates with Virus-like Particles

An unusual dual sugar-binding lectin domain controls the substrate specificity of a mucin-type O-glycosyltransferase